Appendix 3B and Appendix 3Y Withdrawn
(WorldNews Health)

.2 Company Announcement ASX: CUV Nasdaq International Designation: CLVLY XETRA-DAX: UR9 APPENDIX 3B AND APPENDIX 3Y WITHDRAWN ____________________________________________________________________________________________________________________________________ Melbourne, Australia 25 February 2020 CLINUVEL PHARMACEUTICALS LTD ("Company") withdraws the Appendix 3B ("Appendix 3B") and Change of Director`s Interest Notice ("Appendix 3Y") filed by the Company on 5 December 2019. The Appendix 3B and Appendix 3Y relate to the proposed grant of 1,513,750 unlisted performance rights to the CEO (the "Unlisted Performance Rights") under the Performance Plan Rules....